ROS1 and lung carcinoma: We demonstrated that the transcription levels of ALK- or RET-fusion partner genes, such as EML4, CCDC6 and KIF5B, were constitutively activated in lung cancer cells, and the expression at the C-terminal region of ALK, RET, or ROS1 was also markedly elevated in each fusion-positive lung cancer cell.